Inventor · disambiguated record
Xiang Li
Also filed as: LI XIANG · LI XIANG-AN
4 granted patents·11 pending applications·0 citations·filing 2017–2023
54Inventor score
Files withENTRADA THERAPEUTICS INC8ANOVIA BIOSCIENCES INC2MASSACHUSETTS INST TECHNOLOGY2BEIHAO STEM CELL AND REGENERATIVE MEDICINE RES INSTITUTE CO LTD1COYOTE DIAGNOSTICS LAB BEIJING CO LTD1
Top patents by PatentIndex Score
15 records- 0176US12109301B2Formulations, methods, and systems for treating genitourinary conditionsMASSACHUSETTS INST TECHNOLOGY·Filed 2022·Granted Oct 8, 2024·0 cites·15 claims
- 0266US11523985B2Formulations, methods, and systems for treating genitourinary conditionsMASSACHUSETTS INST TECHNOLOGY·Filed 2018·Granted Dec 13, 2022·0 cites·22 claims
- 0366US2025011774A1Antisense compounds and methods for targeting cug repeatsENTRADA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0461US2024417429A1Compositions and methods for skipping exon 45 in duchenne muscular dystrophyENTRADA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0558US2025051393A1Compositions and methods for modulating interferon regulatory factor-5 (irf-5) activityENTRADA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0657US2025051780A1COMPOSITIONS AND METHODS FOR MODULATING mRNA SPLICINGENTRADA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0757US2024358845A1Compositions and methods for intracellular therapeuticsENTRADA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0855US12016864B2LOX enzyme inhibiting methods and compositionsANOVIA BIOSCIENCES INC·Filed 2022·Granted Jun 25, 2024·0 cites·20 claims
- 0955US2024247259A1Compositions and methods for modulating gene expressionENTRADA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1054US2025243244A1Cyclic cell penetrating peptidesENTRADA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1151US2024050522A1COMPOSITIONS AND METHODS FOR PREVENTING, ATTENUATING, AND TREATING MEDICAL CONDITIONS WITH sHDL NANOPARTICLESUNIV MICHIGAN REGENTS·Filed 2021·Application pending·0 cites
- 1249US2023020092A1Compositions for delivery of antisense compoundsENTRADA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1348US2021381054A1Methods, systems and kits for predicting premature birth conditionCOYOTE DIAGNOSTICS LAB BEIJING CO LTD·Filed 2019·Application pending·0 cites
- 1445US2023310445A1Lox enzyme inhibiting methods and compositionsANOVIA BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1535US12018278B2Methods for chemically induced lineage reprogrammingBEIHAO STEM CELL AND REGENERATIVE MEDICINE RES INSTITUTE CO LTD·Filed 2017·Granted Jun 25, 2024·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Xiang Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →